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Background
Rheumatoid arthritis (RA) is associated with increased
incidence of cardiovascular disease (CVD) and heart fail-
ure (HF) compared to the general population. CMR stu-
dies in the general population demonstrate that increases
in left ventricular (LV) mass and early LV structural
changes are predictors of HF in asymptomatic patients.
Previous studies have reported conflicting data on LV
geometry in heterogeneously sampled RA populations.
Objectives
To investigate the influence of disease duration on LV
geometry using CMR by assessing and comparing two
distinct RA populations; a well-defined population of
newly diagnosed, treatment-naive RA and an established
disease group.
Methods
Seventy-five patients underwent CMR at 3.0T (Philips
Achieva TX). None had known CVD or diabetes. 30
were RA patients fulfilling 2010 ACR/EULAR classifica-
tion criteria, with symptoms for less than 1 year, no
therapy with disease modifying anti-rheumatic drugs,
disease activity score (DAS28) ≥3.2 and at least one
poor RA prognostic factor. They were age-matched with
30 RA patients with disease duration >5yrs. 15 healthy
controls were age-matched. Standard balanced steady
state free precession cine images were acquired and LV
dimensions calculated offline. Tissue-tagging for strain
analysis was acquired using a spatial modulation of mag-
netization pulse sequence.
Results
Participant characteristics can be seen in Table 1. Age,
sex, blood pressure and body size were not different
between the 3 groups. The established RA group had
excellent disease control with median(IQR) CRP 0.0mg/
L(5.3) and DAS28 2.0(1.7). CMR measurements are in
table 2. LV systolic performance, using LVEF and Ecc,
was normal and similar in all groups. LV geometry was
similar between early RA patients and healthy controls
(p-values for LVEDV, LV Mass and LV Mass/LVEDV
being 0.19, 0.51 and 0.11 respectively). Indexed LV mass
and LV mass/LVEDV were lower in the established RA
group compared to the early RA group (Mean±SD, 33g
±8/m2 versus 43±9g/m2, p<0.01 and 0.44±0.09g/ml ver-
sus 0.54±0.11g/ml, p<0.01 respectively).
Conclusions
We compare two distinct RA populations and demon-
strate that ventricular systolic performance (LVEF and
Ecc) in the RA population is similar to controls of simi-
lar age. Abnormal LV geometry (LV mass and LVmass/
EDV) is prevalent in asymptomatic patients with estab-
lished RA. LV remodelling appears to occur despite
excellent disease control, with the caveat that this is
cross-sectional disease activity. These insights suggest
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that ventricular remodelling occurs later in RA and that
CMR is a sensitive tool to detect such changes. Addi-
tional longitudinal evaluation can inform on the impact
of inflammation/disease activity over time.
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Table 1 Participant characteristics according to RA status.
Characteristic Early RA n = 30 Established RA n = 30 Healthy Control n = 15 p-value
Age, years 51±8 52±7 51 ± 8 0.81*
Female gender; n (%) 34 (65) 15 (50) 7 (47) 0.14*
Body mass index, kg/m2 27±5 26±4 25±3 0.48*
Body surface area, m2 1.9±0.2 1.8±0.2 1.9±0.2 0.35*
Pulse pressure, mmHg 51±11 57±14 55±14 0.34*
CRP, mg/L, median (IQR) 6.4 (34) 0.0 (5.3) - <0.01
ACPA, n (%) 26 (87) 24 (80) - 0.19
RF, n (%) 25 (83) 21 (70) - 0.14
DAS28, median (IQR) 5.5 (1.7) 2.0 (1.7) - <0.01
Data presented as mean and standard deviation unless otherwise stated. *Appropriate parametric/non-parametric tests applied for 3-way comparison after
normality assessments. ACPA; anti-citrullinated peptide antibody, CRP; C-reactive protein, DAS; Disease activity score, RF; Rheumatoid factor.
Table 2 CMR findings between RA patients and controls.
Measurement Early RA n = 30 Established RA n = 30 Healthy Control n = 15 p-value*
LVEDV indexed, ml/m2 81±15 76±13 87±14 0.07
LV Mass indexed, g/m2 43±9 33±8 41±9 <0.01
LV Mass/LVEDV, g/ml 0.54±0.11 0.44±0.09 0.48± 0.12 <0.01
LVEF, % 60±4 59±4 61±5 0.90
Ecc Mid Ventricle -0.22±0.03 -0.22±0.05 -0.24±0.04 0.22
Data presented as mean+/-SD unless otherwise stated. *Appropriate parametric/non-parametric tests applied for 3-way comparison after normality assessments.
Ecc; Peak systolic strain, EDV; End-diastolic volume, EF; Ejection fraction.
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